CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Income Statement [Abstract]
Design, Contract and Testing Revenue	$ 24,938	$ 54,209	$ 106,236	$ 691,250
Operating Costs and Expenses
Amortization of patents and proprietary technology		2,314		15,958
Cost of revenue	12,572	8,545	42,074	29,206
Administrative and marketing expense	132,783	150,800	393,042	404,287
Research and development expense	80,070	60,498	227,689	213,956
Total Operating Costs and Expenses	225,425	222,157	662,805	663,407
Net Operating Income (Loss)	(200,487)	(167,948)	(556,569)	27,843
Other Income and Expenses
Interest expense	(40,373)	(79,324)	(118,165)	(236,106)
Interest income	15	12	283	35
Gain on extinguishment of debt				90,325
Gain on forgiveness of debt		57,320		57,320
Loss on derivative		(151,673)		(440,367)
Total Other Income (Expense)	(40,358)	(173,665)	(117,882)	(528,793)
Net Loss	$ (240,845)	$ (341,613)	$ (674,451)	$ (500,950)
Basic and Diluted Earnings per Common Share	$ (0.00)	$ (0.00)	$ (0.01)	$ (0.01)
Basic and Diluted Weighted-Average Common Shares Outstanding	99,713,464	95,704,123	99,713,464	94,291,641